Gbola Amusa is a biopharma finance executive. He most recently served as CFO and later EVP, Strategic Finance and Investor Relations at Metsera. During his tenure, Metsera became the fastest company in biotech history to reach a $7.5 billion valuation by advancing next-generation therapies for obesity and metabolic disease.
Prior to this, Amusa was recognized as the #1 ranked European pharma analyst.